Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 7th International Veterinary Congress Paris, France.

Day 1 :

Keynote Forum

Ramesh C. Gupta

Murray State University, USA

Keynote: Nutraceuticals In Animal Health And Disease, With A Special Reference To Osteoarthritis

Time : 08:50-09:20

OMICS International Veterinary 2017 International Conference Keynote Speaker Ramesh C. Gupta photo
Biography:

Ramesh Gupta has earned his DVM, MVSc and PhD from India and currently serves as Professor and Head of Toxicology Department. For decades, he has conducted experimental brain research in relation to pesticide toxicity. He has served the panels of NIH, CDC, NIOSH, and NAS and has published more than 350 publications, including 7 books: Toxicology of Organophosphate & Carbamate Compounds, Veterinary Toxicology, Handbook of Toxicology of Chemical Warfare Agents, Anticholinesterase Pesticides, Reproductive & Developmental Toxicology, Biomarkers in Toxicology and Nutraceuticals. In 2006, he has received the Murray State University's Distinguished Researcher Award. He is a Diplomate of American Board of Toxicology and Fellow of American College of Toxicology, American College of Nutrition and Academy of Toxicological Sciences.

Abstract:

Currently, the nutraceutical industry is worth more than $200 billion per year. Nutraceuticals, commonly referred to as dietary supplements, are given to humans and animals with the intent of improvement of health, and prevention/treatment of diseases. In a number of animal diseases (such as arthritis, dermatitis, diabetes, depression, allergies, obesity, periodontal disease; and gastrointestinal, hepatic, renal, and cardiovascular dysfunction), nutraceuticals have been found very effective. Among all chronic diseases, osteoarthritis (OA) occurs with the greatest frequency, especially in canine and equine species. In fact, one in five adult dogs or horses is inflicted with OA, and factors contributing  to this crippling, chronic degenerative joint disease include aging, injury, obesity, genetics, immune status and nutritional deficiency.  Until recently, OA-associated pain has commonly been managed with the use of non-steroidal anti-inflammatory drugs (NSAIDs), but due to severe side effects in hepatic, renal, and cardiovascular systems, nutraceuticals have been preferred over NSAIDs. Presently, a number of nutraceuticals (glucosamine and chondroitin, type II collagen, Terminalia chebula extract, curcumin, green-lipped mussels, Boswellia serrata extract, shilajit, krill oil fatty acids, methylsulfonylmethane, hyaluronic acid, and others) are indicated singly or in a combination to manage/treat OA in companion animals.  However, nutraceutical efficacy depends on selection, source, dose and the right combination of ingredients.  In general, most nutraceuticals are effective and well tolerated with a wide margin of safety. However, they have not been evaluated for their pharmacological efficacy and safety in large clinical trials. Therapeutic efficacy and safety evaluation of plant-based nutraceuticals, compared to a pure synthetic compound, is complex due to a large number of factors.  In conclusion, the future of nutraceuticals in animal health and diseases seems bright, as novel nutraceuticals will emerge and new uses of old nutraceuticals will be discovered.

Keynote Forum

Srebrenka Nejedli

University of Zagreb, Croatia

Keynote: Exotic species-reptiles and birds in teaching and science

Time : 09:20-09:50

OMICS International Veterinary 2017 International Conference Keynote Speaker Srebrenka Nejedli photo
Biography:

Srebrenka Nejedli is full professor in the Department of Anatomy, Histology and Embryology Faculty of Veterinary Medicine University of Zagreb. She has got two projects, she is member of the Editorial board of two journals, she has formed and designed the subject «Morphology of reptiles» in the Faculty of Veterinary Medicine University of Zagreb and is leader of it and also she is teaching anatomy of domestic animals and birds in graduate and postgraduate studies. Her research interes is anatomy, histology and embriology, she is member of  EAVA and European Aquaculture Society.

Abstract:

Today, veterinarians in the veterinary practice are increasingly faced with exotic species such as reptiles. As patients usually come turtles, snakes and lizards. Their morphology is the foundation for the any further study, and in the curricula of veterinary faculties was not always included. In the Department of Anatomy, Histology and Embryology, Faculty of Veterinary Medicine, University of Zagreb students learning anatomy of birds and there is also an elective course "Morphology of reptiles" where students can get basic knowledge of the morphology of reptiles. As a basis of knowledge for teaching scientific researches are very important in the field of morphology of reptiles and birds. Knowledge of the anatomy of domestic mammals and birds is important in the understanding of morphology of exotic species like reptiles and birds and their differences in the morphology.

OMICS International Veterinary 2017 International Conference Keynote Speaker Yong Ho Park photo
Biography:

Professor Park has achieved his DVM and MS at College of Veterinary Medicine, Seoul National University, Korea. In 1991, he has obtained his PhD in veterinary microbiology at Washington State University, US.  He has worked at National Veterinary Research Institute for 18 years starting from 1978 to 1995 until he moved to Professor at College of Veterinary Medicine, Seoul National University.

He has been appointed as an adjunct Professor at the College of Veterinary Medicine, Washington State University since 1996 and has been also appointed as an affiliate professor at Mississippi State University since 2013.  

Abstract:

One health approaches, ‘One health, one medicine’, have been globally recognized to control zoonotic diseases. World Organization of Animal Health (OIE) has reported 60% of human pathogens are animal origin and more than 75% of emerging animal diseases are zoonoses. This means collaboration and cooperation between animal and human medicine together can only solve the problem. Recent huge outbreaks of HPAI and MERS in Korea have been more pay attention to implement one health approaches in practice. Through the painful experience of these zoonotic diseases we may establish the effective preventive method and early diagnosis as critical control strategies. Antimicrobials have played an important role in maintaining the animal health and in producing the high quality food. The concern that the use of antimicrobials in food animal production can increase the risk of selection of antimicrobial resistant bacteria that may cause failure of treatment has led to international expert meeting and reports. Although the prevalence of zoonotic antimicrobial resistant bacteria in food animals or companion animals is maintained still low, however, resistant genotypes similar to or identical with those of the human isolates were also found in non-human sources. Therefore, the risk management interventions should be urgently implemented. Furthermore, a “One health” approach to antimicrobial use and resistance is essential to minimize the antimicrobial resistance in humans and animals, because these are the responsibility of all three health communities: human health, animal health, and environmental health-communities.

Recent reports have documented MRSA (Methicillin Resistant Staphylococcus aureus) detection in animals, foods and animal workers. Now it is considered as one of the most important zoonotic pathogens. Extended-spectrum β-lactamase (ESBL)-mediated resistance is of considerable importance in both human and veterinary medicine. In a study done in Korea, CTX-M producing E. coli and Salmonella were detected in animals, raw meat, farm environment, and farm workers. These results suggest that a combination of clonal and horizontal transmission is spreading of CTX-M resistant NTS between animal and human sources. Prevention and control of infections in food animals is essential in fighting antimicrobial resistance. It is essential that all parties work together to ensure safe use and to minimize the development of resistance.